Breaking News Instant updates and real-time market news.

COO

Cooper Companies

$240.57

6.5 (2.78%)

, SAIC

SAIC

$75.39

2.32 (3.18%)

13:24
12/07/17
12/07
13:24
12/07/17
13:24

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Cooper Companies (COO), consensus $2.64... Science Applications International (SAIC), consensus 87c... United Natural Foods (UNFI), consensus 60c... Cloudera (CLDR), consensus (24c)... Finisar (FNSR), consensus 30c... American Outdoor Brands (AOBC), consensus 70c.

COO

Cooper Companies

$240.57

6.5 (2.78%)

SAIC

SAIC

$75.39

2.32 (3.18%)

UNFI

United Natural Foods

$49.41

-0.1 (-0.20%)

CLDR

Cloudera

$16.11

0.38 (2.42%)

FNSR

Finisar

$17.48

-0.35 (-1.96%)

AOBC

American Outdoor Brands

$14.24

-0.06 (-0.42%)

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 08

    Jan

COO Cooper Companies
$240.57

6.5 (2.78%)

09/12/17
STFL
09/12/17
NO CHANGE
Target $275
STFL
Buy
Cooper Companies price target raised to $275 after Paragard deal at Stifel
Stifel analyst Jonathan Block said Cooper Companies' (COO) agreement to buy Teva's (TEVA) Paragard intrauterine device for $1.1B is a good fit for Cooper's CSI franchise that helps it achieve greater scale and integration of this product "appears relatively straight forward." Paragard's favorable margin structure leads to significant accretion in year one, noted Block, who raised his price target on Cooper shares to $275 from $265 and keeps a Buy rating on the stock.
09/12/17
BARD
09/12/17
NO CHANGE
Target $273
BARD
Outperform
Cooper Companies weakness on M&A news a buying opportunity, says Baird
Baird analyst Jeff Johnson noted Cooper Companies (COO) announced an acquisition of the Paragard IUD from Teva (TEVA) to expand its women's health offering. The analyst likes the acquisition given its minimal integration risk and solid accretion. He remains a buyer of Cooper stock at current levels and would use any pullbacks tied to the announcement as a buying opportunity. Johnson reiterated his Outperform rating and raised his price target to $273 from $267 on Cooper Companies shares.
09/12/17
JPMS
09/12/17
NO CHANGE
Target $235
JPMS
Neutral
JPMorgan sees mixed reaction to Cooper's acquisition of Paragard
JPMorgan analyst Andrew Hanover expects Cooper Companies' (COO) agreement to purchase Teva Pharmaceuticals' (TEVA) Paragard Intrauterine Device to garner a mixed reaction from investors. It will be hard for the 7% of accretion in FY18 "to be enough," since the stock's 45% rally year-to-date is likely driven by investors focused on its consumer-focused CVI business, and this deal does not fit that thesis, Hanover tells investors in a research note. The analyst keeps a Neutral rating on Cooper with a $235 price target.
09/12/17
WELS
09/12/17
NO CHANGE
WELS
Cooper Companies Paragard IUD deal not cheap but 'good fit,' says Wells Fargo
Wells Fargo analyst Larry Biegelsen notes that Cooper Companies (COO) announced that it will acquire Paragard IUD from Teva (TEVA) for $1.1B cash and expects the transaction to close by the end of CY17. The analyst believes that while deal is not cheap, it appears to be a "good strategic fit." Further, he sees the acquisition as accretive to margins but not sales growth.
SAIC SAIC
$75.39

2.32 (3.18%)

10/25/17
WELS
10/25/17
NO CHANGE
WELS
Wells Fargo upgrades three to Outperform in Government Services
Wells Fargo analyst Ed Caso upgraded CACI (CACI), Leidos (LDOS) and SAIC (SAIC) to Outperform from Market Perform while reiterating Outperform ratings on Booz Allen (BAH) and favorite idea CSRA (CSRA). The analyst sees an improving fundamental backdrop for funding levels and pricing amid a "rising global threat environment." Further, he believes the expected resolution in December of the 2018 federal government appropriations should drive national security funding above the current caps set under the Budget Control Act of 2011, while doing "limited damage" to civilian agency budgets. The sector can also benefit meaningfully from any reduction in the U.S. corporate tax rate, Caso tells investors in a research note. He raised his price target for CACI to $158 from $132, for Leidos to $69 from $58 and for SAIC to $80 from $70.
10/23/17
SBSH
10/23/17
UPGRADE
Target $82
SBSH
Buy
Citi upgrades SAIC to Buy after meeting with management
Citi analyst Jonathan Raviv upgraded SAIC to Buy and raised his price target for the shares to $82 from $79. After spending time with management, the analyst believes the company can grow free cash flow next year, addressing a key investor concern. Further, he notes the recent Aecom (ACM) contract win eliminated the primary risk he outlined in his downgrade a year ago.
10/23/17
SBSH
10/23/17
UPGRADE
Target $82
SBSH
Buy
SAIC upgraded to Buy from Neutral at Citi
Citi analyst Jonathan Raviv upgraded SAIC to Buy and raised his price target for the shares to $82 from $79.
10/25/17
WELS
10/25/17
UPGRADE
WELS
Outperform
SAIC upgraded to Outperform from Market Perform at Wells Fargo
UNFI United Natural Foods
$49.41

-0.1 (-0.20%)

11/14/17
GSCO
11/14/17
INITIATION
Target $41
GSCO
Neutral
United Natural Foods assumed with a Neutral at Goldman Sachs
Goldman analyst Christopher Prykull assumed coverage on United Natural Foods with a Neutral and $41 price target. Prykull said the shift towards mass is pressuring gross margins and will require ongoing opex efficiency to maintain margins.
10/17/17
10/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Freeport McMoRan (FCX) downgraded to Sell from Hold at Deutsche Bank with analyst Chris Terry saying he sees an unfavorable risk/reward profile due to valuation and continued uncertainty at Grasberg. 2. Energy Transfer Partners (ETP) downgraded to Neutral from Buy at Goldman Sachs with analyst Theodore Durbin saying he sees a weaker distribution growth outlook and prefers Energy Transfer Equity (ETE) over Energy Transfer Partners. 3. Darden (DRI) downgraded to Hold from Buy at Argus with analyst John Staszak noting the company is not immune from weak conditions in the casual dining industry. 4. Blue Buffalo downgraded to Neutral from Overweight at JPMorgan analyst Ken Goldman saying he sees a more balanced risk/reward saying the company's sales into traditional channels may be weaker than he expected. 5. United Natural Foods (UNFI) downgraded to Underperform at RBC Capital with analyst Bill Kirk saying there is competitive contract risk from Amazon's (AMZN) acquisition of Whole Foods, as Amazon has the ability, incentive and precedent to decrease reliance United Natural Foods. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/17
RBCM
10/17/17
DOWNGRADE
RBCM
Underperform
United Natural Foods downgraded to Underperform at RBC Capital
10/17/17
RBCM
10/17/17
DOWNGRADE
Target $34
RBCM
Underperform
United Natural Foods downgraded to Underperform at RBC Capital on contract risk
As previously noted, RBC Capital analyst Bill Kirk downgraded United Natural Foods (UNFI) to Underperform from Sector Perform and cut his price target to $34 from $36. Kirk notes that there is competitive contract risk from Amazon's (AMZN) acquisition of Whole Foods, as Amazon has the ability, incentive and precedent to decrease reliance United Natural Foods. Kirk adds there is also continued pressure in other channels.
CLDR Cloudera
$16.11

0.38 (2.42%)

05/23/17
05/23/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cloudera (CLDR) was initiated with an Overweight at JPMorgan, a Buy at Stifel and Deutsche Bank, a Market Perform at JMP Securities, an Equal Weight at Morgan Stanley, and a Neutral at Citi. 2. Emerald Expositions Events (EEX) was initiated with an Outperform at RBC Capital, an Overweight at Barclays, a Buy at BofA/Merrill and Deutsche Bank, as well as a Neutral at Goldman Sachs, Credit Suisse, and Baird. 3. Zymeworks (ZYME) was initiated with an Outperform at Wells Fargo, an Overweight at Barclays, and a Buy at Canaccord. 4. Carvana (CVNA) was initiated with an Outperform at William Blair, JMP Securities, BMO Capital, Wells Fargo, and Baird, as well as a Buy at BofA/Merrill and Citi. 5. J.B. Hunt (JBHT) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/24/17
BOFA
05/24/17
INITIATION
Target $23
BOFA
Neutral
Cloudera initiated with a Neutral at BofA/Merrill
BofA/Merrill initiated Cloudera with a Neutral and a $23 price target.
10/11/17
MZHO
10/11/17
INITIATION
Target $18
MZHO
Neutral
Cloudera initiated with a Neutral at Mizuho
Mizuho analyst Abhey Lamba initiated Cloudera with a Neutral and $18 price target citing valuation.
10/12/17
10/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with an Outperform at Oppenheimer. 2. Cloudera (CLDR) initiated with a Neutral at Mizuho. 3. Tesaro (TSRO) initiated with a Buy at H.C. Wainwright. 4. TechnipFMC (FTI) coverage transferred with a Market Perform at Raymond James. 5. Tactile Systems (TCMD) initiated with a Buy at Guggenheim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
FNSR Finisar
$17.48

-0.35 (-1.96%)

12/04/17
NEED
12/04/17
DOWNGRADE
NEED
Buy
Finisar downgraded to Buy from Strong Buy at Needham
12/04/17
MKMP
12/04/17
NO CHANGE
Target $25
MKMP
Buy
Finisar should acquire Oclaro, says MKM Partners
MKM Partners analyst Michael Genovese expects Finisar's (FNSR) Q2 earnings this week to be soft amid weakness in the 100G Datacom/QSFP28 demand seen recently in peers' results. Genovese says his channel checks also suggest that the company has likely not yet qualified for volume 3D VCSEL shipments to the major smartphone-related customer, which would be a "significant negative" for investors. The analyst keeps his Buy rating and a $25 price target on Finisar, saying that in the longer term the company will participate in 3D VCSEL sales to a major customer in the market in the second half of next year. Meanwhile, Genovese says Finisar should buy Oclaro (OCLR) on its exposure to Electro-absorption Modulated Lasers - EMLs - which are "vastly superior" at 400G, as the 400G Datacom cycle is expected to gain momentum in 2019.
12/04/17
NEED
12/04/17
DOWNGRADE
Target $25
NEED
Buy
Finisar downgraded to Buy at Needham on Data Center market concerns
As reported earlier, Needham analyst Alex Henderson downgraded Finisar to Buy from Strong Buy and lowered his price target to $25 from $34. Henderson says the data on the conditions in the Data Center market "have not been conducive to upside and more consistently suggest risk" amid more aggressive pricing in the segment. Henderson also notes that 100G Data Comm prices have been soft, reducing his expectations for revenues and gross margins on less visibility in the company's business.
12/06/17
STFL
12/06/17
NO CHANGE
Target $23
STFL
Buy
Finisar price target lowered ahead of earnings to $23 at Stifel
Stifel analyst Patrick Newton lowered his Q2 revenue and pro forma EPS estimates for Finisar ahead of the company's upcoming earnings report and cut his price target on the stock to $23 from $27, citing expectations for negative mix shifts, no material rebound in China order trends, and worse than expected 40G revenue due to the shift to 100G. However, he maintain his Buy rating on the shares, saying this is due "largely" to valuation.
AOBC American Outdoor Brands
$14.24

-0.06 (-0.42%)

09/25/17
09/25/17
UPGRADE
Target $19.5

Outperform
American Outdoor Brands upgraded to Outperform at Wedbush
As previously reported, Wedbush analyst James Hardiman upgraded American Outdoor Brands to Outperform from Neutral saying that between his gun consumer survey, distributor channel checks, concealed carry analysis, and upside/downside scenario analysis, he sees an industry that while beleaguered with excess inventory, elevated promotions, and questionable manufacturer strategy, is showing no signs of going away. The analyst also raised his price target on the shares to $19.50 from $16.
09/25/17
WEDB
09/25/17
UPGRADE
WEDB
Outperform
American Outdoor Brands upgraded to Outperform from Neutral at Wedbush
09/20/17
CHLM
09/20/17
NO CHANGE
Target $17
CHLM
Hold
Easing of gun makers export rules could be catalyst, says Craig-Hallum
Craig-Hallum analyst Steven Dyer notes that while details are still vague, commentary suggests that the Trump Administration is contemplating a plan to shift oversight of international non-military firearms sales from the State Department to the Commerce Department, effectively making it easier for U.S. manufacturers to sell guns overseas. The analyst argues that while international sales make up less than 5% of American Outdoor Brands' total revenue, he views this legislation as a potential catalyst to drive increased international sales. He reiterates a Hold rating on the shares, while raising his price target on the stock to $17 from $15.
09/08/17
LSCM
09/08/17
NO CHANGE
Target $13
LSCM
Hold
American Outdoor Brands price target lowered to $13 from $17 at Lake Street
Lake Street analyst Chris Krueger lowered his price target for American Outdoor Brands to $13 saying the company's Q1 results "were weak" despite giving guidance with just four weeks remaining in the quarter. The analyst believes trends fell off in July and have remained weak thus far in Q2. He thinks the industry environment will remain difficult for several more months and keeps a Hold rating on the shares.

TODAY'S FREE FLY STORIES

ORCL

Oracle

$50.19

0.14 (0.28%)

, AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

17:34
12/14/17
12/14
17:34
12/14/17
17:34
Hot Stocks
Breaking Hot Stocks news story on Oracle, Amazon.com »

Oracle says switching…

ORCL

Oracle

$50.19

0.14 (0.28%)

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Mar

EPD

Enterprise Products

$26.07

0.17 (0.66%)

17:33
12/14/17
12/14
17:33
12/14/17
17:33
Hot Stocks
Enterprise Products to implement further oil quality specifications at Cushing »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:31
12/14/17
12/14
17:31
12/14/17
17:31
Hot Stocks
Adobe 'pleased' with subscription bookings and advertising cloud »

Says photography offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

, COST

Costco

$186.53

-1.75 (-0.93%)

17:30
12/14/17
12/14
17:30
12/14/17
17:30
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Jabil…

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

COST

Costco

$186.53

-1.75 (-0.93%)

CNC

Centene

$99.02

-2.17 (-2.14%)

DCIX

Diana Containerships

$4.87

-0.37 (-7.06%)

MS

Morgan Stanley

$52.64

-0.54 (-1.02%)

DDR

DDR Corp.

$7.96

-0.11 (-1.36%)

RMBL

RumbleON

$5.30

-0.06 (-1.12%)

SAH

Sonic Automotive

$20.05

-0.95 (-4.52%)

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

FORM

FormFactor

$14.90

-0.05 (-0.33%)

ORCL

Oracle

$50.19

0.14 (0.28%)

VSTM

Verastem

$3.65

-0.15 (-3.95%)

GBT

Global Blood Therapeutics

$39.40

1.05 (2.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

  • 09

    Jan

AEP

American Electric

$76.29

-0.22 (-0.29%)

17:28
12/14/17
12/14
17:28
12/14/17
17:28
Syndicate
Breaking Syndicate news story on American Electric »

American Electric files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$158.03

-6.62 (-4.02%)

17:25
12/14/17
12/14
17:25
12/14/17
17:25
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Dinner Meeting will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

ORCL

Oracle

$50.20

0.14 (0.28%)

17:24
12/14/17
12/14
17:24
12/14/17
17:24
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Hurd says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:23
12/14/17
12/14
17:23
12/14/17
17:23
Hot Stocks
Adobe targeting subscription bookings growth of 20% in FY18 »

Says expect quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Adobe says advertising cloud had a 'strong' year »

Says advertising cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says currency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:19
12/14/17
12/14
17:19
12/14/17
17:19
Earnings
Oracle sees Q3 adjusted EPS 68c-70c, consensus 72c »

Sees Q3 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

, UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

17:17
12/14/17
12/14
17:17
12/14/17
17:17
Hot Stocks
Urstadt Biddle raises quarterly dividend by 0.5c to 27c »

At their regular meeting…

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
Oracle says customer adoption of cloud products 'remains very strong' »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NQ

NQ Mobile

$4.13

0.02 (0.49%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
NQ Mobile announces partnership with Chery Automotive »

NQ Mobile Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

CVX

Chevron

$119.53

-0.4 (-0.33%)

, SLB

Schlumberger

$62.37

-0.93 (-1.47%)

17:12
12/14/17
12/14
17:12
12/14/17
17:12
Periodicals
Chevron near pact with Schlumberger to drill six Brazil wells, Reuters says »

Chevron (CVX) has reached…

CVX

Chevron

$119.53

-0.4 (-0.33%)

SLB

Schlumberger

$62.37

-0.93 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

VSTM

Verastem

$3.65

-0.15 (-3.95%)

17:07
12/14/17
12/14
17:07
12/14/17
17:07
Syndicate
Verastem files to sell $25M of common stock »

BTIG is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$1.62

0.02 (1.25%)

17:06
12/14/17
12/14
17:06
12/14/17
17:06
Syndicate
Breaking Syndicate news story on Denbury Resources »

Denbury Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$56.52

-1.12 (-1.94%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Initiation
Nicolet Bankshares initiated  »

Nicolet Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GALE

Galena

$0.32

0.0399 (14.24%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Hot Stocks
Galena to adjourn special meeting until Friday, December 29 »

Galena Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDS

FactSet

$202.46

0.44 (0.22%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Initiation
FactSet initiated  »

FactSet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

UTX

United Technologies

$123.76

-0.54 (-0.43%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Hot Stocks
United Technologies awarded $6.7B U.S. Air Force contract »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$28.80

-0.31 (-1.06%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Juniper initiated  »

Juniper resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$37.90

-0.25 (-0.66%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Cisco initiated  »

Cisco resumed with a Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

ANET

Arista Networks

$226.72

1.59 (0.71%)

17:02
12/14/17
12/14
17:02
12/14/17
17:02
Initiation
Arista Networks initiated  »

Arista Networks resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GRA

W.R. Grace

$69.98

-0.46 (-0.65%)

, ALB

Albemarle

$127.58

-2.2 (-1.70%)

17:01
12/14/17
12/14
17:01
12/14/17
17:01
Hot Stocks
W.R. Grace to acquire Polyolefin Catalysts unit of Albemarle for $416M »

W.R. Grace (GRA) signed…

GRA

W.R. Grace

$69.98

-0.46 (-0.65%)

ALB

Albemarle

$127.58

-2.2 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.